Mettler-Toledo International Inc at Barclays Global Healthcare Conference Transcript
And good afternoon, everybody. My name is Jack Meehan, I am the Life Science Tools and Diagnostics Analyst at Barclays. And really pleased to be joined by Mettler-Toledo today and the company's CFO, Shawn Vadala as well as Mary Finnegan, the company's Treasurer and Head of Investor Relations. Before we kick it off, we're going to do 3 audience response questions quick. So please use the Blackberries. Mary, you can participate, too.
#1, what do you view as Mettler's organic growth profile over the next 3 years? I was going to joke. I think we've got 100% mid-single digits, before it was 89%. #2, how confident you are in the outlook for growth in China? 44%, confident. The rest, uncertain or not confident. And then, finally, how would you like to see Shawn deploy capital in 2019? Continue theme focused on investing in the core and M&A.
So Shawn, would you like to make any introductory comments?
Yes.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |